Showing results (471-480 of 710) with videos related to
Sort By:
Pageof 71
Briefings in Bioinformatics|December 5, 2021
Identifying correlations driven by influential observations in large datasetsKevin Bu, David S Wallach, Zach Wilson, et al.Pathologica|March 12, 2010
A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesionsC Clemente, D Bettio, A Venci, et al.The American Journal of Pathology|November 7, 1999
Fluctuation of HER2 expression in breast carcinomas during the menstrual cycleA Balsari, P Casalini, E Tagliabue, et al.Blood|September 25, 1999
Simultaneous phenotypically distinct but clonally identical mucosa-associated lymphoid tissue and follicular lymphoma in a patient with Sjögren's syndromeA Aiello, M Q Du, T C Diss, et al.Current Cancer Drug Targets|August 12, 2008
FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancerD L Cortinovis, F Andriani, A Livio, et al.Medicina Oral, Patologia Oral Y Cirugia Bucal|August 22, 2019
Effects of locally applied Insulin-like Growth Factor-I on osseointegrationJ López-Quiles, A Forteza-López, M Montiel, et al.Hearing Research|March 4, 2026
Neural encoding of speech in noise: Effects of background noise and behavioral correlatesGiannina Puddu-Gallardo, Natàlia Gorina-Careta, Nerea San Martín-González, et al.Tumori|June 11, 1999
Prognostic value of clinicopathologic characteristics including neuroectodermal differentiation in osseous Ewing's sarcoma family of tumors in childrenR Luksch, G Sampietro, P Collini, et al.Cancer Research|June 1, 1996
Aberrant FHIT transcripts in Merkel cell carcinomaG Sozzi, H Alder, S Tornielli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesS Ménard, P Valagussa, S Pilotti, et al.Pageof 71